Will this trial change my practice? PRAMI - treatment of bystander coronary lesions in patients undergoing primary PCI for acute STEMI
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F14%3A00061756" target="_blank" >RIV/65269705:_____/14:00061756 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.4244/EIJV10I3A70" target="_blank" >http://dx.doi.org/10.4244/EIJV10I3A70</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Will this trial change my practice? PRAMI - treatment of bystander coronary lesions in patients undergoing primary PCI for acute STEMI
Original language description
The PRAMI trial, published in the New England Journal of Medicine, investigated in a multicentric randomised fashion whether "on the spot full revascularisation" provides outcome benefits in patients with multivessel disease presenting with a ST-elevation myocardial infarction (STEMI), as compared to a "culprit alone strategy"1. The study enrolled 465 patients with acute STEMI, who underwent primary PCI of the culprit lesion and were randomly assigned 1:1 either to "preventive PCI" of all non-culprit lesions with more than 50% diameter stenosis during the same procedure (234 patients) or to "no preventive PCI" (231 patients). - See more at: http://www.pcronline.com/eurointervention/74th_issue/70/#sthash.iL6yjOy4.dpuf
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů